Not yet recruiting
Phase I/II Trial of Electroporation-Delivered pBI-4 Vaccine (TriGrid™ PVX4) for Treatment of Women With HPV16-Positive CIN1 or Persistent Infection
NCT07809997
- Conditions
- Cervical Intraepithelial Neoplasia Grade 1, Human Papillomavirus 16 Infection
- Locations
-
Not specified